Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolan vs propofol for postoperative delirium in elderly lung cancer surgery patients
ChiCTR2300069205Phase 4Not yet recruiting
- Sponsor
- Shanghai Chest Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in postoperative delirium (POD) and bronchial carcinoma (2 arms), sponsored by Shanghai Chest Hospital. Primary endpoint: Incidence of postoperative delirium. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2300069205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069205.